The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

<h4>Background</h4>Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of i...

Full description

Saved in:
Bibliographic Details
Main Authors: Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS Medicine
Online Access:https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004155&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004155&type=printable

Similar Items